Compound Details
TELINOVA tablets contain Telmisartan (CAS 144701-48-4). Pharmaceutical-grade antihypertensive tablets from NovaTech Sciences for blood pressure control and cardiovascular health support.
Form
Oral tablets
Strength
20 mg Telmisartan per tablet
Packaging
Blister pack of 10 tablets
Tablet Type
Pharmaceutical-grade antihypertensive
Usage Category
Blood pressure management, cardiovascular support, performance wellness
Suitable For
Individuals needing blood pressure control, post-cycle therapy, or cardiovascular protection
TELINOVA Tablets by NovaTech Sciences contain pharmaceutical-grade Telmisartan (CAS 144701-48-4), a widely recognized angiotensin II receptor blocker (ARB) used for blood pressure regulation and cardiovascular health management. Telmisartan is globally identified through CAS 144701-48-4, ensuring chemical authenticity, traceability, and pharmaceutical standardization across international supply chains.
NovaTech Sciences manufactures Telmisartan CAS 144701-48-4 under rigorous quality control procedures to ensure purity, stability, and reliable therapeutic consistency.
Telmisartan is an angiotensin II receptor blocker used to manage hypertension and reduce cardiovascular risk. Registered under CAS 144701-48-4, Telmisartan works by blocking the angiotensin II type-1 receptor, which normally causes blood vessels to tighten and blood pressure to increase.
By inhibiting this receptor, Telmisartan CAS 144701-48-4 allows blood vessels to relax and widen, supporting improved blood flow and healthier blood pressure levels.
The CAS registry number 144701-48-4 confirms the exact chemical identity of Telmisartan, ensuring pharmaceutical accuracy and regulatory transparency.
Telmisartan (CAS 144701-48-4) belongs to the class of medications known as angiotensin II receptor blockers (ARBs). Angiotensin II is a hormone that causes blood vessels to constrict and stimulates the release of aldosterone, which increases sodium and water retention.
Telmisartan blocks this pathway by binding selectively to angiotensin II receptors, preventing vasoconstriction and reducing the workload on the heart.
Each batch of Telmisartan CAS 144701-48-4 undergoes comprehensive testing to ensure formulation accuracy, purity, and stability.
NovaTech Sciences operates as a trusted manufacturer, supplier, and exporter of pharmaceutical-grade antihypertensive medications for global markets. TELINOVA tablets containing Telmisartan CAS 144701-48-4 are produced under strict pharmaceutical manufacturing guidelines.
These processes ensure that Telmisartan tablets meet regulatory expectations in professional pharmaceutical distribution networks.
NovaTech Sciences prioritizes quality assurance, regulatory compliance, and pharmaceutical reliability. TELINOVA tablets are developed with verified Telmisartan CAS 144701-48-4 to provide dependable antihypertensive formulations for global markets.
For those seeking a dependable source of Telmisartan (CAS 144701-48-4), TELINOVA Tablets by NovaTech Sciences provide pharmaceutical-grade antihypertensive support with verified chemical identity and consistent manufacturing standards. With rigorous quality control and global supply capabilities, Telmisartan CAS 144701-48-4 remains a trusted compound for blood pressure management and cardiovascular health support.
Precautions
Contraindications
Telmisartan is a prescription antihypertensive compound identified by CAS Number 144701-48-4. It belongs to the angiotensin II receptor blocker class, commonly known as ARBs. Nova Techsciences presents Telmisartan as the active compound associated with its TELINOVA tablet range.
Telmisartan is used in authorised medical settings for the treatment of essential hypertension in adults. Certain authorised products are also used to reduce cardiovascular events in appropriately assessed high-risk patients. The exact indication must always reflect the approved product information in the country where the medicine is supplied.
Angiotensin II is a naturally occurring substance that causes blood vessels to tighten and encourages the body to retain sodium and water. Telmisartan selectively blocks angiotensin II type-1 receptors, helping blood vessels relax and reducing the pressure against which the heart must pump.
As a prescription medicine, Telmisartan requires individual clinical assessment. Blood pressure, kidney function and electrolyte levels may require monitoring, particularly in patients with existing kidney disease, cardiovascular conditions or other medicines that affect the renin–angiotensin system.
A dependable Telmisartan compound profile should be supported by documented analytical controls. These may include:
Every batch should carry a unique identification number linked to its manufacturing history and laboratory-release results. Claims involving purity, pharmaceutical quality or manufacturing compliance should only be published when supported by current documentation.
Telmisartan should only be used under qualified medical supervision. Possible adverse effects include dizziness, reduced blood pressure and changes in kidney function or potassium levels. Medicines acting on the renin–angiotensin system can harm a developing foetus, making pregnancy an important contraindication requiring immediate professional review.
For the UK, Netherlands and other European markets, Nova Techsciences should clearly state the applicable marketing-authorisation status, prescription category, responsible organisation and adverse-event reporting process.
Chlorodehydromethyltestosterone, identified by CAS Number 2446-23-3, is an anabolic-androgenic steroid chemically unrelated to Telmisartan. Its compound page should independently address regulatory status, liver and cardiovascular risks, batch traceability and prominent warnings against sporting or unsupervised use.
Levothyroxine Sodium is a synthetic thyroid hormone associated with CAS Number 55-03-8. It is used in authorised thyroid-replacement treatment and requires precise strength control, thyroid-function monitoring and clear warnings against unsupervised weight-loss or metabolism-related use.
Cabergoline, identified by CAS Number 81409-90-7, is a dopamine-receptor agonist used in selected prolactin-related conditions. Its product information should separately cover cardiovascular assessment, low-blood-pressure precautions, medicine interactions, pregnancy considerations and professional monitoring.
Fluoxymesterone is an androgenic and anabolic steroid identified by CAS Number 76-43-7. It has a different mechanism and risk profile from Telmisartan. Its compound information should prioritise liver, cardiovascular, hormonal and reproductive precautions alongside its verified legal status.
Liothyronine Sodium is an active synthetic thyroid hormone identified by CAS Number 55-06-1. It is used in selected thyroid-related clinical circumstances and requires careful thyroid and cardiovascular monitoring. It should not be presented for unsupervised metabolism or weight-management purposes.
Telmisartan should ultimately be presented through accurate chemical identification, transparent quality documentation, balanced medical information and clearly stated regulatory status.
Premium aromatase inhibitor tablets for estrogen suppression and effective hormone balance support.
Buy Tamoxifen Citrate (CAS 54965-24-1) by NovaTech Sciences. Premium tablets for estrogen modulation, hormone support, and targeted receptor activity.
Buy Anastrozole (CAS 120511-73-1) by NovaTech Sciences. Pharmaceutical-grade aromatase inhibitor tablets for estrogen suppression and hormone regulation.
